Matthias Totzeck

Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy

Lars Michel, Iris Helfrich, Ulrike B. Hendgen‐Cotta et al. · European Heart Journal · 2021 · 149 citations

Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial

Axel Bauer, Michael Schreinlechner, Nikolay Sappler et al. · The Lancet Respiratory Medicine · 2021 · 101 citations · Full text

Open-label Trial, Hypertension, Cardiovascular Disease +9

Cardiac fibroblast activation detected by Ga-68 FAPI PET imaging as a potential novel biomarker of cardiac injury/remodeling

Johannes Siebermair, Miriam Köhler, Jana Kupusović et al. · Journal of Nuclear Cardiology · 2020 · 95 citations · Full text

Contemporaneous 3D characterization of acute and chronic myocardial I/R injury and response

Simon F. Merz, Sebastian Korste, Lea Bornemann et al. · Nature Communications · 2019 · 85 citations · Full text

Visualization of Fibroblast Activation After Myocardial Infarction Using 68Ga-FAPI PET

Lukas Kessler, Jana Kupusović, Justin Ferdinandus et al. · Clinical Nuclear Medicine · 2021 · 73 citations